Chemed Revenue 2010-2024 | CHE

Chemed annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Chemed revenue for the quarter ending March 31, 2024 was $0.589B, a 5.19% increase year-over-year.
  • Chemed revenue for the twelve months ending March 31, 2024 was $2.293B, a 5.96% increase year-over-year.
  • Chemed annual revenue for 2023 was $2.264B, a 6.06% increase from 2022.
  • Chemed annual revenue for 2022 was $2.135B, a 0.2% decline from 2021.
  • Chemed annual revenue for 2021 was $2.139B, a 2.87% increase from 2020.
Chemed Annual Revenue
(Millions of US $)
2023 $2,264
2022 $2,135
2021 $2,139
2020 $2,080
2019 $1,939
2018 $1,783
2017 $1,667
2016 $1,577
2015 $1,543
2014 $1,456
2013 $1,413
2012 $1,430
2011 $1,356
2010 $1,281
2009 $1,190
Chemed Quarterly Revenue
(Millions of US $)
2024-03-31 $589
2023-12-31 $586
2023-09-30 $565
2023-06-30 $554
2023-03-31 $560
2022-12-31 $547
2022-09-30 $526
2022-06-30 $531
2022-03-31 $531
2021-12-31 $541
2021-09-30 $539
2021-06-30 $532
2021-03-31 $527
2020-12-31 $533
2020-09-30 $528
2020-06-30 $502
2020-03-31 $516
2019-12-31 $522
2019-09-30 $481
2019-06-30 $474
2019-03-31 $462
2018-12-31 $458
2018-09-30 $444
2018-06-30 $442
2018-03-31 $439
2017-12-31 $428
2017-09-30 $417
2017-06-30 $415
2017-03-31 $406
2016-12-31 $403
2016-09-30 $393
2016-06-30 $390
2016-03-31 $390
2015-12-31 $399
2015-09-30 $386
2015-06-30 $382
2015-03-31 $377
2014-12-31 $379
2014-09-30 $358
2014-06-30 $360
2014-03-31 $358
2013-12-31 $349
2013-09-30 $341
2013-06-30 $357
2013-03-31 $367
2012-12-31 $369
2012-09-30 $354
2012-06-30 $354
2012-03-31 $353
2011-12-31 $350
2011-09-30 $341
2011-06-30 $333
2011-03-31 $331
2010-12-31 $336
2010-09-30 $320
2010-06-30 $315
2010-03-31 $309
2009-12-31 $303
2009-09-30 $297
2009-06-30 $295
2009-03-31 $295
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.076B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00